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In a review published in 2004 [1] and that still repays 
reading  today,  Cecile  Pickart  traced  the  evolution  of 
research  on  ubiquitination  from  its  origins  in  the 
proteasomal  degradation  of  proteins  through  the 
revelation that it has a central role in cell cycle regulation 
and the recognition of regulatory roles for ubiquitin in 
intracellular  membrane  transport,  cell  signalling, 
transcription, translation, and DNA repair.
Pickart’s article marked the expansion of ubiquitination 
from what most regarded as a niche preoccupation, with 
implications only for housekeeping protein turnover and 
the destruction of damaged ribosomal products, to seize 
the attention and excite the imagination of researchers in 
every area of cell biology. Comparisons to phosphorylation 
are rife – specific ubiquitin ligases promote ubiquitina  tion 
and  deubiquitinating  enzymes  terminate  its  effects  of 
ubiquitination  just  as  ubiquitination  just  as  kinases 
and  phosphatases  induce  and  terminate  the  effects  of 
phosphorylation  –  though  ubiquitination,  unlike 
phosphorylation, can operate irreversibly, by delivering 
its targets to the proteasome: hence its vital role in the 
progression of the cell cycle.
It  was  already  clear  in  2004  that  the  number  of 
ubiquitinating  and  deubiquitinating  enzymes  was  very 
large, and that ubiquitin tags can be attached to proteins 
either as monomers or as poly-ubiquitin chains. But it 
had only recently been discovered that there are at least 
seven different kinds of poly-ubiquitin chains, and how 
the diversity of poly-ubiquitin signals is generated and 
interpreted in cells was in large part territory still to be 
explored.
In  a  series  of  articles  the  first  three  of  which  are 
published  this  month,  we  review  what  is  now  known 
about  some  of  the  central  issues  in  research  on 
ubiquitination, revisiting the questions of how ubiquitin 
signals  are  conjugated  to  and  removed  from  specific 
targets, and how they are recognized and contribute to 
the regulation of central processes in cells.
Where are we now?
Ubiquitin is a protein of 76 amino acids whose structure 
is shown in Figure 1. It is attached to a lysine in its target 
proteins either as a monomer or as a poly-ubiquitin chain 
each monomer of which is linked through its carboxy-
terminal  glycine  to  (usually)  a  lysine  in  the  preceding 
ubiquitin in the chain. Three enzymes, known generically 
as E1, E2 and E3, act in series to catalyze ubiquitination 
(Figure 2). The E1 is the ubiquitin-activating enzyme, to 
which ubiquitin becomes attached in an ATP-dependent 
reaction  through  a  reactive  thioester  bond.  E2  is  the 
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Figure 1. The structure of ubiquitin. Ubiquitin is a small, compact 
protein characterized by a b-grasp fold. The seven lysines that can 
be linked to the terminal glycine of another ubiquitin molecule 
to form poly-ubiquitin chains are colored red. The green shading 
indicates the hydrophobic patch through which ubiquitin interacts 
with specific ubiquitin-binding proteins.  Image created by Masato 
Akatsu, Frankfurt University. 
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transferred from the E1; and E3 is the ubiquitin ligase, 
which binds the target protein and directly or indirectly 
catalyzes its ligation to the ubiquitin. The E3 therefore 
determines  the  substrate  specificity  of  ubiquitination, 
and  the  diversity  of  the  cellular  functions  of 
ubiquitination  is  reflected  in  the  existence  of  some 
hundreds of different mammalian E3s, compared with a 
few dozen E2s and two E1s.
The E2 conjugating enzymes have special significance 
in  determining  the  type  of  ubiquitin  chain  assembled. 
There are seven lysines in ubiquitin, and poly-ubiquitin 
chains can be assembled through linkage to any of the 
seven:  the  distinct  chains  are  known  as  K6,  K11,  K27, 
K29,  K33,  K48  and  K63  chains,  depending  upon  the 
lysine through which the monomers are linked. In most 
cases (the so-called RING E3 ligases – see below – with 
are by far the most numerous) it is the E2 that decides 
which type of chain is made. This generalization, and the 
generalization  that  ubiquitination  involves  linkage 
through a lysine fell victim in 2006 to the discovery that 
ubiquitin chains can be formed through linkage between 
the  carboxy-terminal  glycine  of  one  ubiquitin  and  the 
amino-terminal methionine of another, to form so-called 
linear ubiquitin chains; and in this case it is the E3 (a 
complex known as LUBAC) that determines the linkage 
(see [2]). What we now know of the mechanism of linear 
ubiquitin  chain  assembly  and  the  function  of  linear 
ubiquitin  chains  in  immune  signaling  is  discussed  by 
Henning Walczak, Kazuhiro Iwai and Ivan Dikic [2] in 
one of the three inaugural reviews published this month.
A  third  generalization  has  succumbed  to  research 
described in the second article, from Dawn Wenzel and 
Rachel Klevit [3]. E3 ubiquitin ligases have until recently 
been  classified  as  belonging  to  one  of  two  structurally 
and functionally distinct families: the HECT ligases, and 
the RING/Ubox ligases. The mechanisms of these ligases 
are lucidly outlined by Wenzel and Klevit and illustrated 
schematically  in  their  Figure  1.  Briefly,  whereas  in  the 
case  of  the  HECT  ligases,  the  ubiquitin  is  transferred 
from the E2 to the E3, which then directly catalyzes its 
attachment  to  the  substrate,  in  the  RING  ligases,  the 
ubiquitin  is  transferred  from  the  E2  to  the  substrate 
bound by the E3 (Figure 3). The RBR ligases, which are 
the topic of the article by Wenzel and Klevit, contain a 
Figure 2. Three enzymes act in sequence to ubiquitinate targets. The E1 enzyme is the activating enzyme, to which ubiquitin is attached in an 
ATP-dependent reaction by a thioester bond (shown in red). The E2 enzyme is the conjugating enzyme, to which the ubiquitin is transferred from 
the E1. The E3 is the ubiquitin ligase, which directly or indirectly catalyzes the transfer of the ubiquitin to the target protein (the substrate), with the 
formation of an isopeptide bond (shown in black).
Figure 3. HECT and RING ligases act by different mechanisms. 
HECT E3 ligases (top) directly catalyze the attachment of ubiquitin 
to the substrate, whereas in the case of RING ligases (bottom) the 
ubiquitin is transferred from the E2 which, with the substrate, is 
bound to the E3. Exactly how the catalytic action of E2 is facilitated 
by the RING E3 is not known. Reactive thioester bonds are shown in 
red; the isopeptide bond with the target (substrate) protein is shown 
in black.
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RING-type E3s, and had been regarded as a subclass of 
RING  ligases;  but  it  transpires  that  the  RBR  ligases 
behave more like the HECT family of E3s, and directly 
transfer  the  ubiquitin  to  the  target  protein.  The  active 
enzyme  in  the  LUBAC  complex  belongs  to  the  RBR 
subclass of E3s, helping to explain its eccentric behaviour. 
These  fresh  insights  however  raise  again  outstanding 
issues  of  how  the  different  domains  of  these  ligases 
contribute to their catalytic action and the type of chain 
assembled by them, and show how astonishingly little is 
still known about some of the fundamental mechanisms 
of ubiquitination.
Beyond ligases
The world beyond the assembly of ubiquitin chains and 
the  attachment  of  ubiquitin  to  cellular  targets  now 
encompasses  all  of  cell  biology.  Ubiquitin  chains  of 
different linkages have distinct structural properties the 
principles  of  whose  recognition  by  ubiquitin-binding 
proteins have yet to be fully explored. In particular, it is 
not  known  how  the  ubiquitin-binding  modules  that 
recognize  mono-ubiquitins  and  the  different  poly-
ubiquitin  chains  achieve  the  specificity  for  different 
ubiquitin  species,  and  how  this  is  translated  into 
physiological  responses.  Recent  studies  have  provided 
initial data about the mechanisms of deconjugation and 
functions  of  deubiquitinating  enzymes,  but  many 
questions on the specificity of deubiquitinating enzymes 
and their roles in cell-specific functions remain open.
In the third review published this month, Simona Polo 
reaches into the territory of cell biology and explores the 
contribution  of  ubiquitination  to  the  regulation  of  cell 
signaling by endocytosis [4], drawing parallels with the 
regulation  at  many  levels  of  signaling  pathways  by 
phosphorylation. The critical issue here is how ligand-
induced signaling regulates the activity of the E3 ligases 
that ubiquitinate receptors to initiate endocytic sorting 
for  subsequent  receptor  degradation  in  the  lysosome. 
Another important contribution of ubiquitination to the 
regulation  of  endocytosis  is  the  ubiquitination  of 
endocytic  adaptor  molecules  through  a  process  called 
coupled  mono-ubiquitination  that  can  be  either  E3-
dependent and E3-independent.
Later articles in the series will confront some of the 
many  open  issues  in  research  on  ubiquitination,  and 
extend  the  exploration  of  its  contributions  to 
fundamental cell biological processes.
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